Suchergebnisse - %22Pandemic%22

PubPharm (8)

1

Selenium nanoparticles incorporated in nanofibers media eliminate H1N1 activity : a novel approach for virucidal antiviral and antibacterial respiratory mask

enthalten in: Environmental science and pollution research international | 2024

von Boroumand, S. | Majidi, R. | Gheibi, A. | +1

2

Adaptive Mutation in the Main Protease Cleavage Site of Feline Coronavirus Renders the Virus More Resistant to Main Protease Inhibitors

enthalten in: Journal of virology | 2022

von Jiao, Z. | Yan, Y. | Chen, Y. | +8

3

Anti-HIV and anti-HCV small molecule protease inhibitors in-silico repurposing against SARS-CoV-2 Mpro for the treatment of COVID-19

enthalten in: Journal of biomolecular structure & dynamics | 2022

von Sultan, A. | Ali, R. | Ishrat, R. | +1

4

Human genetic risk of treatment with antiviral nucleoside analog drugs that induce lethal mutagenesis : The special case of molnupiravir

enthalten in: Environmental and molecular mutagenesis | 2022

von Waters, M. | Warren, S. | Hughes, C. | +2

5

Potential Antiviral Properties of Industrially Important Marine Algal Polysaccharides and Their Significance in Fighting a Future Viral Pandemic

enthalten in: Viruses | 2021

von Geetha Bai, R. | Tuvikene, R.

6

Identifying FDA-approved drugs with multimodal properties against COVID-19 using a data-driven approach and a lung organoid model of SARS-CoV-2 entry

enthalten in: Molecular medicine (Cambridge, Mass.) | 2021

von Duarte, R. | Copertino, D. | Iñiguez, L. | +7

7

Identification of Main Protease of Coronavirus SARS-CoV-2 (Mpro) Inhibitors from Melissa officinalis

enthalten in: Current drug discovery technologies | 2021

von Elekofehinti, O. | Iwaloye, O. | Famusiwa, C. | +2

8

The lysosome : A potential juncture between SARS-CoV-2 infectivity and Niemann-Pick disease type C, with therapeutic implications

enthalten in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology | 2020

von Ballout, R. | Sviridov, D. | Bukrinsky, M. | +1

1
[1]